Category Archives: Vascular Biology

Tissue source and processing Paired sections of tissue, including both artery and plaque, were recovered from the atherosclerotic core (AC) and proximally adjacent (PA) region of three patients with asymptomatic type VII calcified plaques who underwent carotid endarterectomy (Fig. Continue reading →

Dissecting policies and practices, offering solutions informed by scholarship and lived experience. Continue reading →

The SIU System Inventor of the Year Award recognizes innovators who perform exemplary work in the field of technologies, discoveries, innovations, and made outstanding contributions to the SIU system during the past five years. Naoufal Lakhssassi, who uses genes to help plants resist diseases and improve their seed composition and content, fits the bill for such an award, receiving it in September 2022 during the SIU board of trustees meeting. An associate scientistin the Department of Plant, Soil and Agricultural Systems, Lakhssassi is a molecular physiologist, geneticist, genomicist, and TILLING expert who discovered and cloned novel disease-resistant genes and seed-trait genes using TILLING technology, along with mutation breeding in soybeans. Continue reading →

In mylast macroeconomic modeling paperI compared my model outputs to the long-term pattern in global energy and GDP data (seemy blog discussing the main takeaways). The energy data were arranged by colleagueAndrew Jarvisas we discussed in thispre-print paper(a revised version again in peer review). The data we discussed were those relating global primary energy consumption to real gross domestic product (GDP) of all countries (see Figure 1, left) Continue reading →

October 13, 2022 Zach Williams thought hed become a cancer researcher when he joined Virginia TechsTranslational Biology, Medicine, and Health Graduate Programthree years ago. But during a trial stint in the lab ofRob Gourdie, a cardiovascular scientist who is a professor and director of theCenter for Vascular and Heart Researchat theFralin Biomedical Research Institute at VTC, Williams changed direction. While studying a molecule the lab had designed, Williams discovered something new about the way it works Continue reading →

Houston researchers and clinicians are finding ways to personalize patient care with groundbreaking treatments. Cancer is one of humanitys greatest health challenges, killing millions of people every year. For decades, treatment for the disease has focused primarily on surgery (removing it) and chemotherapy and radiation therapy (attacking it). Continue reading →

Expand 'Those with very severe ME lie motionless, are tube fed, suffer multiple level pain, suffer periodic paralysis, blood pressure and heart issues, muscle weakness, numbness, cognitive dysfunction, visual difficulties, muscle spasms, multiple sensitivities, gut issues, sleep issues.' Sufferers of myalgic encephalomyelitis, or ME, have long felt disregarded by some medical professionals who believed their pain and exhaustion to be a psychological disorder. More recently, patient activism, combined with new data on the underlying biology of the illness, has resulted in changes in treatment guidelines and a renewed focus on ME as a biologically grounded post-viral disease. There is no official record of how many people in Ireland suffer from ME, but international prevalence rates suggest it affects between 10,000 and 19,000 people here. Continue reading →

VANCOUVER, BC, Oct. 13, 2022 /PRNewswire/ --Data Bridge Market Research has recently published a report, titled, "Global MHealth Solutions Market". The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape Continue reading →

Introduction Vitiligo is a cutaneous depigmentation disorder characterized by the selective loss of melanocytes. Continue reading →

FUROSCIX demonstrated 99.6% bioavailability and produced similar diuresis and natriuresis compared to intravenous furosemide Commercial launch planned in Q1 2023 BURLINGTON, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. Continue reading →